We are focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. The Company's first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya® (andexanet alfa), and Bevyxxa® (betrixaban). The company also is advancing cerdulatinib, an investigational SYK/JAK inhibitor being developed for the treatment of hematologic cancers. We are continuing to explore new discoveries that impact how serious blood-related disorders are treated and expanding the potential impact of our existing portfolio of medicines.
View Top Employees from Portola Pharmaceuticals| Website | http://www.portola.com/ |
| Ticker | PTLA |
| Revenue | $40 million |
| Funding | $458.2 million |
| Employees | 95 (95 on RocketReach) |
| Founded | 2003 |
| Address | 270 East Grand Ave., South San Francisco, California 94080, US |
| Phone | (650) 246-7000 |
| Fax | (650) 246-7376 |
| Technologies |
Slack,
AWS Route53,
Shopify
+41 more
(view full list)
|
| Industry | Pharmaceuticals, Business Services, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biopharma, Biotechnology / Pharmaceutical, Biotechnology, Discovery Tools (Healthcare), Healthcare, Health Care, Science and Engineering, Therapeutics, Medical Testing & Clinical Laboratories, Manufacturing, Power Conversion & Protection Equipment, Aerospace & Defense, Electronics, Organizations, Education |
| Web Rank | 766401 |
| Web Visits | 61140 |
| Keywords | Portola Pharmaceuticals, Portola Pharmaceuticals Inc, Portola, Lexicon Pharmaceuticals, Inc., Portola Pharmaceuticals I |
| Competitors | Acceleron Pharma, Adamas Pharmaceuticals, Inc., Anesiva, Pharmaceutical Company, Reata Pharmaceuticals, Inc. |
| SIC | SIC Code 37 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 5417 Companies |
Looking for a particular Portola Pharmaceuticals employee's phone or email?
Portola Pharmaceuticals Questions
The Portola Pharmaceuticals annual revenue was $40 million in 2024.
Randy Laurent is the Vice President Sales of Portola Pharmaceuticals.
95 people are employed at Portola Pharmaceuticals.
Portola Pharmaceuticals is based in South San Francisco, California.
The NAICS codes for Portola Pharmaceuticals are [54, 3254, 32, 541, 325, 32541, 5417].
The SIC codes for Portola Pharmaceuticals are [37, 28].
Top Portola Pharmaceuticals Employees
-
35+
-
ViewShannon DiNapoli
Executive Director, Regulatory Affairs at Portola Pharmaceuticals
California, United States23 -
View
Bruce Koch
Executive Director, Medical Affairs at Portola Pharmaceuticals
California, United States5+5+ -
View
Charlotte Furey
Director, Clinical Data Management at Portola Pharmaceuticals
San Francisco, CA, US25+ -
1
Related Companies
